Literature DB >> 25784568

Reliable timescale inference of HBV genotype A origin and phylodynamics.

Gianguglielmo Zehender1, Valentina Svicher2, Elena Gabanelli3, Erika Ebranati3, Carla Veo3, Alessandra Lo Presti4, Eleonora Cella4, Marta Giovanetti4, Linda Bussini3, Romina Salpini2, Claudia Alteri2, Alessia Lai3, Elisabetta Tanzi5, Carlo Federico Perno2, Massimo Galli3, Massimo Ciccozzi4.   

Abstract

The worldwide distributed Hepatitis B virus (HBV) genotype A is classified into three subgenotypes, and one quasi-subgenotype. The majority of HBV-A subgenotypes are widespread in Africa and in ethnic groups that have relatively recently emigrated from African countries, whereas HBV-A2 is highly prevalent among subjects at high risk for sexual exposure to HBV in north-western Europe and the USA. The aim of this study was to reconstruct the origin and dispersion of HBV-A subgenotypes on a reliable timescale using short-term calibration based on heterochronous sampling for HBV-A2, and long-term calibration based on historical data for the other subgenotypes. To this aim, we analysed 113 newly characterised HBV-A isolates with 247 reference sequences retrieved from a public database. The phylodynamic reconstruction was performed by a Bayesian framework. The common ancestor of the currently circulating A subgenotypes was placed in west-central Africa a mean 1057 years ago. The genotype diverged into two main clades at the beginning of the 13th century: one including all of the west-central African quasi-subgenotypes and the other corresponding to subgenotype A1, originating in east Africa and further segregating into two main subclades: an "African" and a "cosmopolitan" clade. It is likely that the slave trade was the main source the spread of cosmopolitan HBV-A1, which was exported to Asia in the 17th century as a result of Arab or Portuguese trade, and to Latin America in the 18th centuries through the trans-Atlantic slave trade. The origin of the currently circulating A2 strains dates back to the first decades of the 20th century, and the evolutionary demography analysis suggests an exponential growth of infections, between 1970s and the mid-1990s. In conclusion, the very different epidemiological and evolutionary histories of HBV-A subgenotypes justify the use of different calibration approaches to reconstruct their reciprocal phylodynamics.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HBV genotype A; HBV subgenotype A1; HBV subgenotype A2; Hepatitis B virus; Molecular clock calibration; Phylogeography

Mesh:

Year:  2015        PMID: 25784568     DOI: 10.1016/j.meegid.2015.03.009

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  5 in total

Review 1.  Origins and Evolution of the Primate Hepatitis B Virus.

Authors:  Stephen A Locarnini; Margaret Littlejohn; Lilly K W Yuen
Journal:  Front Microbiol       Date:  2021-05-24       Impact factor: 5.640

2.  Hepatitis B virus genotypes A1, A2 and E in Cape Verde: Unequal distribution through the islands and association with human flows.

Authors:  Isabel Inês M de Pina-Araujo; Natalia Spitz; Caroline C Soares; Christian Niel; Barbara V Lago; Selma A Gomes
Journal:  PLoS One       Date:  2018-02-15       Impact factor: 3.240

3.  Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations.

Authors:  Jolynne Mokaya; Tetyana I Vasylyeva; Eleanor Barnes; M Azim Ansari; Oliver G Pybus; Philippa C Matthews
Journal:  J Viral Hepat       Date:  2021-05-07       Impact factor: 3.517

Review 4.  Integrating molecular epidemiology and social network analysis to study infectious diseases: Towards a socio-molecular era for public health.

Authors:  Tetyana I Vasylyeva; Samuel R Friedman; Dimitrios Paraskevis; Gkikas Magiorkinis
Journal:  Infect Genet Evol       Date:  2016-06-02       Impact factor: 3.342

5.  Genetic Diversity of the Hepatitis B Virus Subgenotypes in Brazil.

Authors:  Barbara V Lago; Marcia P do Espirito-Santo; Vanessa D Costa; Vanessa A Marques; Livia M Villar; Lia L Lewis-Ximenez; Elisabeth Lampe; Francisco C A Mello
Journal:  Viruses       Date:  2019-09-15       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.